About

The Living Therapeutics Initiative (LTI) brings together UCSF’s vast scientific and clinical expertise to accelerate research and quickly advance promising therapies to clinical trials for patients who have few, if any, good treatment options.

Who We Are

Alan Ashworth, PhD, FRS
Head, Living Therapeutics Initiative

E. Dixon Heise Distinguished Professor in Oncology
President, UCSF Helen Diller Family Comprehensive Cancer Center
Senior Vice President for Cancer Services, UCSF Health
Professor of Medicine, Division of Hematology/Oncology, Department of Medicine

Krishna Komanduri, MD
Clinical Director, Living Therapeutics Initiative

Professor and Chief, Division of Hematology and Oncology, Dept. of Medicine
Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center

Brian Shy, MD, PhD
Director, Development and Manufacturing, Living Therapeutics Initiative

Medical Director, Human Islet and Cellular Transplant Facility
Processing Facility Director, Pediatric Cell Therapy Lab
Assistant Professor In Residence, Laboratory Medicine